106.818 articles found

A Case Series Highlighting Complexities in the Management of Bipolar Disorder With Parkinson’s Disease

Pepper J.

BJPsych open · 2025-06-20

Initial Audit Investigating Physical Health Screening and Management of Neuropsychiatric Manifestations in Parkinson’s Disease (PD), Parkinson’s Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB) on the Mental Health Services for Older Persons (MHSOP) Wards

Qureshi M, Elias T, Ikuforiji O, Okafor C, Cohen S.

BJPsych open · 2025-06-20

Impulse Control Disorders and Other Compulsive Behaviours in Parkinson’s Disease – What Is Current Evidence of Treatment?

Gross A.

BJPsych open · 2025-06-20

Parkinson’s Disease With Psychosis: A Case Report of Neuropsychiatric Manifestations

Alewad S.

BJPsych open · 2025-06-20

Insights into retention and safety/tolerability of apomorphine sublingual film in patients with Parkinson's disease and OFF episodes: post hoc analyses of a phase III, open-label study.

Kassubek J, Santos Garcia D, Jost WH, Wojtecki L, Moreira F, Fonseca MM, Harrison-Jones G, Pijuan I, Denecke Muhr C.

Ther Adv Neurol Disord · 2025-06-20

DOI: 10.1177/17562864251343583PMID: 40547865

Insights into gait performance in Parkinson's disease via latent features of deep graph neural networks.

Wu J, Su N, Li X, Yao C, Zhang J, Zhang X, Sun W.

Front Neurol · 2025-06-20

DOI: 10.3389/fneur.2025.1567344PMID: 40621096

Unraveling α-synuclein and amylin co-aggregation: pathological insights and biomarker development for Parkinson's disease.

Zhou Y, Lai M, Shu B, Wang B, Wang D, Liu H, Li B, Guo J, Hu D, Li M, Zhu C, Kang M, Li ZA, Wang R, Zhao Y, Tuan RS, Guo K, Li C, Jiang C.

Theranostics · 2025-06-20

DOI: 10.7150/thno.112396PMID: 40756347

A community-led initiative to de-risk and advance Parkinson's disease therapeutic targets.

Vaiana A, Behr J, Birol R, Blauwendraat C, Casey B, Chowdhury K, Citron M, Crapser J, Dardov V, Ducotterd F, Dumanis S, Dunlop J, Durborow M, Fiske B, Golden J, Hannestad J, Hung W, Kemp J, Kleiman R, Knight A, Koemeter-Cox A, Leuchter B, Logsdon BA, Marreiros R, Miller JE, Mitchell A, Mukherjee P, Navarro G, Nelson MR, Nikolich K, Otis T, Polinski N, Rastegar-Pouyani S, Reith AD, Riley E, Rubin L, Ryten M, Sadick J, Schwabe T, Sherer T, Silvergleid S, Singleton A, St Clair L, Stoehr J, Stone DJ, Sullivan J, Tanenbaum N, Tinelli E, Trimble K, Wang Y, Weninger S, Wiggenhauser N, Wood S, Schoepp D, Buggia-Prevot V, Padmanabhan S, Skibinski G.

NPJ Parkinsons Dis · 2025-06-20

DOI: 10.1038/s41531-025-01039-3PMID: 40541945

Dopamine and cortical neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction.

Chedid J, Li Y, Labrador-Garrido A, Abu-Bonsrah D, Pavan C, Fraser T, Ovchinnikov D, Zhong M, Davis R, Strbenac D, Johnston JA, Thompson LH, Kirik D, Parish CL, Halliday GM, Sue CM, Wali G, Dzamko N.

NPJ Parkinsons Dis · 2025-06-20

DOI: 10.1038/s41531-025-01048-2PMID: 40541941

A novel fusion architecture for detecting Parkinson's Disease using semi-supervised speech embeddings.

Adnan T, Abdelkader A, Liu Z, Hossain E, Park S, Islam MS, Hoque E.

NPJ Parkinsons Dis · 2025-06-20

DOI: 10.1038/s41531-025-00956-7PMID: 40541966

Evaluating language model embeddings for Parkinson's disease cohort harmonization using a novel manually curated variable mapping schema.

Salimi Y, Adams T, Ay MC, Balabin H, Jacobs M, Hofmann-Apitius M.

Sci Rep · 2025-06-20

DOI: 10.1038/s41598-025-06447-2PMID: 40542087

Clinical progression and genetic pathways in body-first and brain-first Parkinson's disease.

Passaretti M, Veréb D, Mijalkov M, Chang YW, Zhao H, Zufiria-Gerbolés B, Sun J, Volpe G, Rivera N, Bologna M, Pereira JB.

Mol Neurodegener · 2025-06-20

DOI: 10.1186/s13024-025-00866-5PMID: 40542411